Evidence map›Paper›PMID 40666031›Full record

ReviewSmall science2025

Fluorescent Antibiotics: Bridging Diagnostic and Therapy in the Fight against Bacterial Infections.

Tan Phuoc Ton, Richard Bright, Vi Khanh Truong, Krasimir Vasilev

Abstract readReview
In one paragraph

Review in Small science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. An All-in-One Au@CeOAdvanced healthcare materials · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tan Phuoc TonBiomedical Nanoengineering Laboratory College of Medicine and Public Health Flinders University Bedford Park SA 5042 Australia.
Richard BrightBiomedical Nanoengineering Laboratory College of Medicine and Public Health Flinders University Bedford Park SA 5042 Australia.ORCID https://orcid.org/0000-0003-1988-0725
Vi Khanh TruongBiomedical Nanoengineering Laboratory College of Medicine and Public Health Flinders University Bedford Park SA 5042 Australia.ORCID 0000-0002-6016-6438
Krasimir VasilevBiomedical Nanoengineering Laboratory College of Medicine and Public Health Flinders University Bedford Park SA 5042 Australia.ORCID https://orcid.org/0000-0003-3534-4754

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections caused by pathogenic bacteria pose a significant threat to human health. Fluorescent antibiotics present an innovative material class that combines diagnostic capabilities with therapeutic effects. Fluorescent antibiotics offer a transformative strategy by combining precise visualization of bacterial activity with targeted antimicrobial action, addressing key challenges like drug resistance and rapid pathogen detection in diagnostics and treatment. This review highlights recent advances in the development of fluorescent antibiotics, focusing on chemical strategies such as click chemistry, amide bond formation, solid-phase peptide synthesis, and epoxy-amine addition. Also, the practical applications of these fluorescent probes, ranging from imaging, rapid detection, and real-time visual tracking of pathogenic bacteria to the detailed study of molecular dynamics at the cellular level are discussed. The opportunity to combine detection and treatment of infectious diseases underscores the significant promise of these probes, particularly in the face of escalating antimicrobial resistance. However, despite the promise, most studies are confined to laboratory settings. To move forward, continued innovation and rigorous clinical validation will be essential to translating these promising molecular tools from laboratory research to impactful clinical applications.

Indexed as

bacterial infectionsdiagnosticsfluorescent antibioticsfluorescent probesimagings

Identifiers

PMID40666031
PMCPMC12257909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.